Grants per year
Search results
-
Finished
Exploring the Role of T-cell Associated Pulmonary Vasculature Injury and Right Ventricular Dysfunction
Cuttica, M. J. (PD/PI), Budinger, G. S. (Other), Kalhan, R. (Other) & Mylvaganam, R. J. (Other)
Actelion Pharmaceuticals US, Inc.
10/1/21 → 9/30/22
Project: Research project
-
A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19
Cuttica, M. J. (PD/PI), Martin, K. A. (PD/PI) & Martin, K. A. (PD/PI)
BloodCenter of Wisconsin, Inc., National Heart, Lung, and Blood Institute
4/19/21 → 6/30/24
Project: Research project
-
Prot #CTEPH.AI: Historical CTPA Cases for Machine Learning/Artificial Intelligence Development
Cuttica, M. J. (PD/PI)
8/12/20 → 8/12/23
Project: Research project
-
Prot #AC-065B302: SELECT: SELExipag in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Group-Sequential, Adaptive, Phase 3 Study with Open-Label
Cuttica, M. J. (PD/PI)
Janssen Research & Development, LLC
8/12/19 → 11/30/24
Project: Research project
-
Prot #AC-055-510: (ORPHEUS) Multicenter, retrospective chart review of first-time Opsumit® (macitentan) users in the United States
Cuttica, M. J. (PD/PI)
PRA Health Sciences, Actelion Pharmaceuticals Ltd.
3/20/18 → 3/20/21
Project: Research project
-
Prot #402-C-1602: An Extended Access Program to Assess Long-Term Safety of Bardoxolone Methy in Patients with Pulmonary Hypertension
Cuttica, M. J. (PD/PI)
PPD Investigator Services, LLC, Reata Pharmaceuticals, Inc.
6/28/17 → 6/30/23
Project: Research project
-
Prot #AC-055-404: A randomized, double-blind, placebo-controlled, prospective, multicenter, parallel group study to assess the safety and efficacy of macitentan in patients with portopulmonary hypertension
Cuttica, M. J. (PD/PI)
PRA Health Sciences, Actelion Pharmaceuticals Ltd.
10/8/15 → 1/31/23
Project: Research project
-
Prot #BPS-314d-MR-PAH-302: A multicenter, double-blind, randomized, placebo-controlled, Phase 3 study to assess the efficacy and safety of oral BPS-314d-MR added-on to treprostinil, inhaled (Tyvaso®) in subjects with pulmonary arterial hypertension
Cuttica, M. J. (PD/PI)
8/12/15 → 2/12/24
Project: Research project
-
Prot #AC-055-503: US-based, observational, drug registry of Opsumit® (macitentan) new users in clinical practice
Cuttica, M. J. (PD/PI)
PRA Health Sciences, Actelion Pharmaceuticals Ltd.
5/28/15 → 5/28/21
Project: Research project
-
Lung Function Decline and Disease Risk from Young Adulthood to Middle Age
Kalhan, R. (PD/PI), Cuttica, M. J. (Co-Investigator), Liu, K. (Co-Investigator), Liu, L. (Co-Investigator) & Shah, S. J. (Co-Investigator)
National Heart, Lung, and Blood Institute
8/1/14 → 12/31/19
Project: Research project
-
Prot# AC-063B201: A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients with Pulmonary Hypertension Secondary to Chroni
Cuttica, M. J. (PD/PI), Dematte D'Amico, J. E. (Co-PD/PI), Kalhan, R. (Co-PD/PI), Rosenberg, S. R. (Co-PD/PI) & Shah, S. J. (Co-PD/PI)
3/19/12 → 3/19/15
Project: Research project
-
Prot#RIN-PH-403: A Postmarketing Observational Study to Assess Respiratory Tract Adverse Events in Pulmonary Arterial Hypertension Patients Treated with Tyvaso (Treprostinil) Inhalation Solution
Cuttica, M. J. (PD/PI), Dematte D'Amico, J. E. (Co-PD/PI) & Shah, S. J. (Co-PD/PI)
United Therapeutics Corporation
9/29/11 → 2/28/15
Project: Research project
-
(TERMINATED 05/01/2012) Prot# BA-I-H-0903: Randomized, Multi-Centre, Controlled Clinical Study on the Effect of the S.A.F.E. bt Therapy on Disease Severity and Inflammation in Mechanically-Ventilated Subjects due to Severe Sepsis
Wunderink, R. G. (PD/PI), Cuttica, M. J. (Co-PD/PI), Dematte D'Amico, J. E. (Co-PD/PI), Ghossein, C. (Co-PD/PI) & Weiss, C. H. (Co-PD/PI)
Theorem Clinical Research, SAFE bt, INC.
6/10/11 → 6/10/14
Project: Research project
-
AGMT 02/10/11: CONFRONT PAH: CombinatiON up-FRON t Therapy for PAH-A Phase 4, Randomized, Multicenter Study of Inhaled Treprostinil in Treatment-naive Pulmonary Arterial Hypertension Patients Starting on Tadalafil
Cuttica, M. J. (PD/PI), Dematte D'Amico, J. E. (Co-PD/PI) & Shah, S. J. (Co-PD/PI)
United Therapeutics Corporation
2/10/11 → 2/10/17
Project: Research project
-
Prot# AC-063A402: A Phase IIIb, Multicenter, Open-Label Study of Patients with Pulmonary Arterial Hypertension Treated with Iloprost (Inhalation) Evaluating Safety and Inhalation Times When Converting from Power Disc-6 to Power Disc-15 With the I-Neb AAD
Dematte D'Amico, J. E. (PD/PI), Cuttica, M. J. (Co-PD/PI) & Shah, S. J. (Co-PD/PI)
Paragon Biomedical, Inc., Actelion Ltd.
5/14/09 → 5/14/12
Project: Research project
-
Prot# CA-ALT-836-01-08: Efficacy and Safety Evaluation of ALT-836 in Patients with Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Wunderink, R. G. (PD/PI), Cuttica, M. J. (Co-PD/PI), Dematte D'Amico, J. E. (Co-PD/PI), Jain, M. (Co-PD/PI) & Weiss, C. H. (Other)
4/20/09 → 4/20/12
Project: Research project